Medical Pharmaceutical Supply – Lidocaine and Prilocaine Periodontal Gel

The contract mandates the supply of FDA-approved lidocaine and prilocaine periodontal gel that meets all regulatory requirements for medical use, including strict adherence to packaging, labeling, and delivery standards. The product must be compliant with federal pharmaceutical guidelines to ensure safety, efficacy, and traceability throughout the supply chain, with all components aligned for use in dental and oral surgical procedures within military and federal healthcare settings. The offering is intended for procurement under a subcontract arrangement, with specifications tied to the NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The solicitation, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, is active with a response deadline of July 27, 2026, and was posted on July 20, 2026. While no set-aside designation or specific place of performance is detailed, the contract requires full compliance with federal medical supply protocols and delivery timelines to support the Department of Defense’s pharmaceutical inventory and clinical needs. Subcontractors must demonstrate proven capability in manufacturing and distributing sterile, regulated dental anesthetics under federal oversight, without reliance on proprietary or non-approved formulations. All bids must align with the terms outlined in the DIBBS platform listing referenced in the contract data.